Bevacizumab improved progression-free survival in patients with ovarian cancer but was not shown to affect overall survival.

Oncology Live   >   Specialty Focus

The 9th International Symposium on Ovarian Cancer and Other Gynecologic Malignancies conference will bring professionals in the field up to date on the latest research into ovarian, uterine, cervical, and endometrial cancers.

Oncology Live   >   Specialty Focus

This commentary will highlight 2 phase III randomized trials and a retrospective review of a large national database that has been strongly criticized based on its overall conclusions.

Oncology Live   >   Conference Highlights

New data show that roughly one-fifth of tamoxifen-treated male patients with breast cancer stop treatment early because of side effects.

Oncology & Biotech News   >   Clinical Trial Reports

The use of a navigation program for an urban safety net breast cancer population has only a moderate effect on the time from symptom presentation to treatment.

Oncology & Biotech News   >   Clinical Trial Reports

New data show that while men are diagnosed with breast cancer at a mere fraction of the rate of women, they tend to have more advanced disease at the time of diagnosis.

Oncology & Biotech News   >   Clinical Trial Reports